Adam Mulkern
banner
mulkern.bsky.social
Adam Mulkern
@mulkern.bsky.social
Postdoc - high-throughput experimental evolution - AMR @ University of Oxford
Had a short but sweet visit to Zürich to speak at @ethz.ch. Many thanks to @phagemuffin.bsky.social and @aharms485.bsky.social!
September 22, 2025 at 8:47 AM
What a month...I spent June in the US at the @cshlnews.bsky.social Advanced Bacterial Genetics course and then the GRC Molecular Mechanisms in Evolution! I met so many cool people along the way — special shoutout to my course lab partner, Max!
July 6, 2025 at 3:35 PM
Hopped over to Northern Ireland last week to give a talk at @qubelfastofficial.bsky.social for their AMR seminar series. Thanks very much to @rwheatley8.bsky.social, @lindaoyama.bsky.social, and @sharonhuws.bsky.social for hosting me!
May 19, 2025 at 10:29 AM
Wrapped up 2024 with the @typaslab.bsky.social in Heidelberg @embl.org, doing some evolution experiments with @stefanbassler.bsky.social. Had an incredible time and looking forward to an exciting year of science in 2025!
December 20, 2024 at 9:03 AM
Reposted by Adam Mulkern
Stress-testing #asobiotics@mulkern.bsky.social & @mgalactus.bsky.social from @twincore.bsky.social, in collaboration with the Vogel lab at the Helmholtz Institute Würzburg, have employed in-vitro laboratory evolution to study how different bacteria develop resistance to programmable antibiotics. 👇
We used in-vitro laboratory evolution to "stress test" the next generation class of antibiotics based on antisense oligos ("asobiotics"). Head over to our new preprint to find out more!

www.biorxiv.org/content/10.1...
November 4, 2024 at 3:10 PM
Excited to share something from my previous postdoc with
@mgalactus.bsky.social, a collaboration with the lab of Jörg Vogel using lab evolution to see how different bacterial species develop resistance to programmable antibiotics:
A systematic identification of resistance determinants to antisense antibiotics suggests adaptation strategies dependent on the delivery peptide
The rise of antimicrobial resistance (AMR) among human pathogenic microbes is a serious threat to global health, calling for the development of novel treatment strategies. Antibiotics based on program...
www.biorxiv.org
October 30, 2024 at 4:59 PM
Thanks to @rwheatley8.bsky.social for organising a lovely AMR & Microbiome workshop @magdalenoxford.bsky.social
May 23, 2024 at 6:01 PM